These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 26374950)
1. What's new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents. Wiederhold NP; Patterson TF Curr Opin Infect Dis; 2015 Dec; 28(6):539-45. PubMed ID: 26374950 [TBL] [Abstract][Full Text] [Related]
2. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Fera MT; La Camera E; De Sarro A Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707 [TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
4. New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species. Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Dos Santos ALS Curr Top Med Chem; 2019; 19(28):2527-2553. PubMed ID: 31654512 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Kanafani ZA; Perfect JR Clin Infect Dis; 2008 Jan; 46(1):120-8. PubMed ID: 18171227 [TBL] [Abstract][Full Text] [Related]
9. Role of antifungal susceptibility testing in patient management. Forrest G Curr Opin Infect Dis; 2006 Dec; 19(6):538-43. PubMed ID: 17075328 [TBL] [Abstract][Full Text] [Related]
10. Current status of antifungal resistance and its impact on clinical practice. Alcazar-Fuoli L; Mellado E Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533 [TBL] [Abstract][Full Text] [Related]
11. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances]. Cuenca-Estrella M Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554 [TBL] [Abstract][Full Text] [Related]
12. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related]
13. Echinocandins--new antifungal agents. Stan CD; Tuchiluş C; Stan CI Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):528-36. PubMed ID: 25076727 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility testing in fungi: a global perspective on a variety of methods. Lass-Flörl C; Perkhofer S; Mayr A Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786 [TBL] [Abstract][Full Text] [Related]
16. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance. Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605 [TBL] [Abstract][Full Text] [Related]
17. Combination antifungal therapy: the new frontier. Vazquez JA Future Microbiol; 2007 Apr; 2(2):115-39. PubMed ID: 17661650 [TBL] [Abstract][Full Text] [Related]
18. New and investigational triazole agents for the treatment of invasive fungal infections. De Sarro A; La Camera E; Fera MT J Chemother; 2008 Dec; 20(6):661-71. PubMed ID: 19129062 [TBL] [Abstract][Full Text] [Related]
19. How can we bolster the antifungal drug discovery pipeline? Jampilek J Future Med Chem; 2016 Aug; 8(12):1393-7. PubMed ID: 27464242 [No Abstract] [Full Text] [Related]
20. An insight into new strategies to combat antifungal drug resistance. Zheng YH; Ma YY; Ding Y; Chen XQ; Gao GX Drug Des Devel Ther; 2018; 12():3807-3816. PubMed ID: 30464412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]